UNH Raises Full-Year 2025 Earnings Outlook After Strong Q3 Revenue Performance

UnitedHealth Group (UNH.US) reported robust financial results for the third quarter of 2025, with revenues reaching $113.2 billion, marking a 12% increase year-over-year. The company's adjusted earnings per share (EPS) for the quarter stood at $2.92, falling short of the analyst estimate of $2.8. Following this performance, UnitedHealth Group raised its full-year 2025 adjusted earnings outlook to at least $16.25 per share.

Key Business Drivers

The growth in the third quarter was significantly driven by strong performances across its segments. UnitedHealthcare's revenues surged 16% year-over-year to $87.1 billion, primarily fueled by expansion in Medicare & Retirement and Community & State sectors. Domestically, UnitedHealthcare successfully served 50.1 million consumers, an increase of 795,000 year-over-year.

Optum also contributed to the overall revenue increase, with its revenues growing 8% year-over-year to $69.2 billion. This growth was largely propelled by the performance of Optum Rx, which saw a 16% increase in revenues, driven by higher script volumes from both new and existing clients, as well as growth in pharmacy services.

Management Outlook

Management expressed confidence in the company's strategic direction and reiterated its focus on strengthening performance for future growth. UnitedHealth Group raised its 2025 earnings outlook, projecting net earnings of at least $14.90 per share and adjusted net earnings of at least $16.25 per share. This revised outlook reflects continued solid execution towards their goal of durable and accelerating growth in 2026 and beyond.